1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4 Sterile Injectables Outlook
Table 1: Sterile Injectables Market By Type
5 Global Sterile Injectables: Growth and Forecast
5.1 By Value (2013-2017)
Table 2:Global Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
5.2 By Value (2018-2023)
Table 3: Global Sterile Injectables Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Table 4: Global Health Expenditure Per Capita,(2012-2016, USD Trillion)
Table 5: Global Health Expenditure Per Capita, By Select Countries,(2016, USD)
Table 6: Global Population Aged 65 and Above, 2012-2015 (% of Total)
Table 7: Global Diabetic Population, By Region, 2015 (Billion)
Table 1: Recent Mergers and Collaborations in Sterile Injectables Industry
6. Global Sterile Injectables Market Segmental Analysis
6.1 Global Sterile Injectables Market By Molecule Type
6.1.1 By Type, 2017 (%)
Table 8: Global Sterile Injectables Market Size, By Molecule Type, 2017 (%)
6.1.2 By Type, 2023 (%)
Table 9: Global Sterile Injectables Market Size, By Molecule Type, 2023F (%)
6.2 Global Biologic Sterile Injectables Market, By Value (2013-2023)
Table 10: Global Biologic Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 11: Global Biologic Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
6.3 Global Small Molecule Sterile Injectables Market, By Value (2013-2023)
Table 12: Global Small Molecule Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 13: Global Small Molecule Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
6.4 Global Sterile Injectables Market By Biologic Drug Type
6.4.1 By Type, 2017 (%)
Table 14: Global Sterile Injectables Market Size, By Type, 2017 (%)
6.4.2 By Type, 2023 (%)
Table 15: Global Therapeutic and Monitoring Devices Market Size, By Type, 2023F (%)
6.5 Global Monoclonal Antibody Sterile Injectables Market, By Value (2013-2023)
Table 16: Global Monoclonal Antibody Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 17: Global Monoclonal Antibody Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Table B: List of Some Monoclonal Antibody Drugs Available in Market
Table C: Antibody therapeutics in late-stage clinical studies for non-cancer indications.
Table D: Antibody therapeutics in late-stage clinical studies for non-cancer indications.
Table E: Antibody therapeutics in late-stage clinical studies for Cancer Indications.
Table F: Antibody therapeutics in late-stage clinical studies for Cancer Indications
6.6 Global Insulin Sterile Injectables Market, By Value (2013-2023)
Table 18: Global Insulin Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 19: Global Insulin Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Table 20: Top 10 Leading countries with diabetes Prevalence, Million, 2017
Table 21: Highest Revenue Generating Insulin Drugs in 2016 & 2017
Table G: List of Some Insulin Sterile Injectables Drugs Available in Market
Table H: List of Some Insulin Sterile Injectables Drugs Available in Market
Table I: List of Insulin Manufacturers, in Selected Countries
6.7 Global Vaccines Sterile Injectables Market, By Value (2013-2023)
Table 22: Global Vaccines Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 23: Global Vaccines Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Table 24: Market Share of Leading Vaccines Manufacturers
Table 25: Global Vaccine Doses Consumption, By Income Group (Million,2016)
Table J: GlaxoSmithKline Vaccine Pipeline
Table K: Pfizer Vaccine Pipeline
6.8 Global Fusion Proteins Sterile Injectables Market, By Value (2013-2023)
Table 26: Global Fusion Proteins Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 27: Global Fusion Proteins Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
6.9 Global Immunoglobulins Sterile Injectables Market, By Value (2013-2023)
Table 28: Global Immunoglobulins Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 29: Global Immunoglobulins Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
6.10 Global Others Biologic Sterile Injectables Market, By Value (2013-2023)
Table 30: Global Others Biologic Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 31: Global Others Biologic Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
6.11 Global Sterile Injectables Market By Indication
6.11.1 By Indication, 2017 (%)
Table 32: Global Sterile Injectables Market Size, By Indication, 2017 (%)
6.11.2 By Indication, 2023 (%)
Table 33: Global Sterile Injectables Market Size, By Indication, 2023F (%)
6.12 Global Sterile Injectables For Oncological Disorders Market, By Value (2013-2023)
Table 34: Global Sterile Injectables For Oncological Disorders Market Size, By Value, 2013-2017 (USD Billion) T
Table 35: Global Sterile Injectables For Oncological Disorders Market Size, By Value 2018E-2023F (USD Billion)
Table 36: Number of People With Cancer, By Type, 2016 (Million)
6.13 Global Sterile Injectables For Infectious Disorders Market, By Value (2013-2023)
Table 37: Global Sterile Injectables For Infectious Disorders Market Size, By Value, 2013-2017 (USD Billion)
Table 38: Global Sterile Injectables For Infectious Disorders Market Size, By Value 2018E-2023F (USD Billion)
Table 39: Global Prevalence of Different Type of Infectious Disorders (2016,%)
Table 40: Global Prevalence of Infectious Disorders (2012-2016, Million)
Table 41: Global Prevalence of Neglected Tropical Disorders in (2012-2016, Million)
Table 42: Global Prevalence of Neglected Tropical Disorders, By Type (2016,%)
6.14 Global Sterile Injectables For Metabolic Disorders Market, By Value (2013-2023)
Table 43: Global Sterile Injectables For Metabolic Disorders Market Size, By Value, 2013-2017 (USD Billion)
Table 44: Global Sterile Injectables For Metabolic Disorders Market Size, By Value 2018E-2023F (USD Billion)
Table 45: Global Diabetes Prevalence (2017&2045, Million)
6.15 Global Sterile Injectables For Cardiovascular Disorders Market, By Value (2013-2023)
Table 46: Global Sterile Injectables For Cardiovascular Disorders Market Size, By Value, 2013-2017 (USD Billion)
Table 47: Global Sterile Injectables For Cardiovascular Disorders Size, By Value 2018E-2023F (USD Billion)
Table 48: Cardiovascular Disease Prevelance, By Type ,2016
Table 49: Global Prevalence of Cardiovascular Disease (2012-2016 , Million)
6.16 Global Sterile Injectables For Neurological Disorders Market, By Value (2013-2023)
Table 51: Global Sterile Injectables For Neurological Disorders Market Size,, By Value 2018E-2023F (USD Billion)
Table 52: Neurological Disorders Prevalence, By Type ,2016
Table 53: Global Prevalence of Neurological Disorders (2012-2016 , Billion)
6.17 Global Sterile Injectables For Musculoskeletal Disorders Market, By Value (2013-2023)
Table 54: Global Sterile Injectables For Musculoskeletal Disorders Market Size, By Value, 2013-2017 (USD Billion)
Table 55: Global Sterile Injectables For Musculoskeletal Disorders Market Size, By Value 2018E-23F (USD Billion)
Table 56: Musculoskeletal Disorders Prevalence, By Type , 2016
6.18 Global Others Indication Sterile Injectables Market, By Value (2013-2023)
Table 58: Global Others Indication Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 59: Global Others Indication Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
6.19 Global Sterile Injectables Market By Distribution Channel
Table 60: Global Prevalence of Gynecological Disorder (2012-2016, Million)
Table 61: Global Prevalence of Gynecological Disorder, By Type 2016
Table 62: Global Prevalence of Sense Organ Disorder (2012-2016, Million)
6.19.1 By Distribution Channel, By Value, 2017 (%)
Table 63: Global Sterile Injectables Market Size, By Distribution Channel, 2017 (%)
6.19.2 By Distribution Channel, By Value, 2023 (%)
Table 64: Global Sterile Injectables Market Size, By Distribution Channel, 2023F (%)
6.20 Global Hospital Pharmacy Sterile Injectables Market, By Value (2013-2023)
Table 65: Global Hospital Pharmacy Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 66: Global Hospital Pharmacy Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
6.21 Global Retail Pharmacy Sterile Injectables Market, By Value (2013-2023)
Table 67: Global Retail Pharmacy Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 68: Global Retail Pharmacy Sterile Injectables Market Size, , By Value 2018E-2023F (USD Billion)
6.22 Global Ecommerce Sterile Injectables Market, By Value (2013-2023)
Table 69: Global Ecommerce Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 70: Global Ecommerce Sterile Injectables Market Size, By Value 2018E-2023F (USD Billion)
Table 71: Percentage of Oncology Drugs Distributed Through Various Channels
7. Global Sterile Injectables Market: Regional Analysis
7.1 Global Sterile Injectables Market Size, By Region : Breakdown (%)
7.1.1 By Region, By Value, 2017 (%)
Table 72: Global Sterile Injectables Market Size and Share, By Region, 2017
7.1.2 By Region, By Value, 2023 (%)
Table 73: Global Sterile Injectables Market Size and Share, By Region, 2023F
7.2 North America Sterile Injectables Market: An Analysis
7.2.1 By Value (2013-2017)
Table 74: North America Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 75: Number of deaths due to cancer in North America
Table 76: North America Population above 65 year in Million
7.2.2 By Value (2018-2023)
Table 77: North America Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
7.2.3 By Molecule Type, By Value (2013-2023)
Table 78: North America Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
7.2.4 By Biologic Drug Type, By Value (2013-2023)
Table 79: North America Sterile Injectables Market : By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
7.2.5 By Indication, By Value (2013-2023)
Table 80: North America Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
7.3 North America Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
Table 81: North America Prevalence of Neurological Disorder (2012-2016, Million)
Table 82: North America Prevalence of Neurological Disorder, By Type 2016
Table 83: North America Prevelnace of Musculoskeletal Disorders (2012-2016, Million)
Table 84: North America Prevalence of Gynecological Disorders (2012-2016)
Table 85: Total Number of People with North America Neglected Tropical Disorders (2012-2016)
Table 86: Total Number of People in North America with Different Type of Cardiovascular Disease in 2016
Table 87: North America Sterile Injectables Market : By Distribution Channel, By Value, 2013-2023 (USD Billion)
Table 88: North America Sterile Injectables Market, Country Share, 2017 (% of Total)
Table 89: North America Sterile Injectables , Country Share, 2023 (% of Total)
7.3.1 U.S Sterile Injectables Market, By Value (2013-2023)
Table 90: United States Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
7.3.2 U.S Sterile Injectables Market, By Indication, By Value (2013-2023)
Table 91: United States Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Table 92: U.S. Per Capita Health Expenditure, 2012-2016 ( USD)
Table 93: U.S. Population Ages 65 and above, 2014 and Forecast (Million)
Table 94: Per Capita Healthcare Expenditure in United States (2012-2016, USD)
Table 95: U.S Health Spending by Type of Service or Product, 2016 (%)
Table 96: United Sates Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 97: United States Prevalence of Cardiovascular Disorders, By Type in 2016
Table 98: New Estimated Cases of Cancer in United States (2014-2018)
Table 99: New Estimated Cases of Cancer in United States, By Gender 2018
Table 100: New Estimated Cases of Cancer in United States, By Type 2018
Table 101: United States Prevalence of Diabetes (Per 1,00,000 )2013-2016
Table 102: United States Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Table 103: Prevalence of Neurological Disorders in United States (2016, Million)
Table 104: United States Prevalence of Cardiovascular Disorders (Per 1,00,000 )20
7.3.3 Canada Sterile Injectables Market, By Value (2013-2023)
Table 105: Canada Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
7.3.4 Canada Sterile Injectables Market, By Indication, By Value (2013-2023)
Table 106: Canada Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Table 107: Canada Per Capita Health Expenditure, 2012-2016 ( USD)
Table 108: Canada Population Ages 65 and above, (% of Total,2012-2016)
Table 109: Canada Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 110: Canada Prevalence of Diabetes (Per 1,00,000 )2013-2016
Table 111: Canada Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Table 112: Canada Total Number of People With Sense Organ Disorders (2012-2016)
Table 113: Canada Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
7.4 Europe Sterile Injectables Market: An Analysis
7.4.1 By Value (2013-2017)
Table 114: Europe Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 115: Percentage of Male and Female deaths due to cancer in EU 28 2016
7.4.2 By Value (2018-2023)
Table 116: Europe Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
7.4.3 By Molecule Type, By Value (2013-2023)
Table 117: Europe Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
7.4.4 By Biologic Drug Type, By Value (2013-2023)
Table 118: Europe Sterile Injectables Market : By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
7.4.5 By Indication, By Value (2013-2023)
Table 119: Europe Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
7.4.6 By Distribution Channel, By Value (2013-2023)
Table 120: Europe Sterile Injectables Market : By Distribution Channel, By Value, 2013-2023 (USD Billion)
7.5 Europe Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
Table 121: Western Europe Prevalence of Gynecological (2012-2016, Million)
Table 122: Western Europe Prevalence of Musculoskeletal Disorders (2012-2016, Million)
Table 123: Total Number of People With Cardiovascular Disorders in Western Europe, By Type,2016
Table 124: Europe Sterile Injectables Market, Country Share, 2017 (% of Total)
Table 125: Europe Sterile Injectables Market, Country Share, 2023 (% of Total)
7.5.1 Germany Sterile Injectables Market, By Value (2013-2023)
Table 127: Germany Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
7.5.2 Germany Sterile Injectables Market, By Indication, By Value (2013-2023)
Table 128: Germany Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 129: Germany Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Table 130: Total Number of People With Infectious Disorder in Germany (2012-2016)
Table 131: Germany Prevalence of Neurological Disorders (2012-2016, Million)
Table 132: Germany Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
7.5.3 United Kingdom Sterile Injectables Market, By Value (2013-2023)
Table 133: United Kingdom Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 134: United Kingdom Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
7.5.4 United Kingdom Injectables Market, By Indication, By Value (2013-2023)
Table 135: United Kingdom Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 136: Estimated Number of People Living with cancer in United Kingdom
Table 137: United Kingdom Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016
Table 138: United Kingdom Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Table 139: United Kingdom Prevalence of Disorders (Per 1,00,000 )2013-2016
7.5.5 Rest of Europe Sterile Injectables Market, By Value (2013-2023)
Table 140: Rest of Europe Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 141: Rest of Europe Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
7.7 APAC Sterile Injectables Market: An Analysis
7.7.1 By Value (2013-2017)
Table 142: Asia Pacific Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 143: Ranking of countries from Asia-Pacific in the Global Access to Healthcare Index
Table 144: Mobile health revenue forecast in Asia Pacific in 2017, by country (in billion U.S. dollars)
7.7.2 By Value (2018-2023)
Table 145: Asia Pacific Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
7.7.3 By Molecule Type, By Value (2013-2023)
Table 146: Asia Pacific Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
7.7.4 By Biologic Drug Type, By Value (2013-2023)
Table 147: Asia Pacific Sterile Injectables Market : By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
7.7.5 By Indication, By Value (2013-2023)
Table 148: Asia Pacific Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 149: Prevalence of Neurological Disorders in South East Asia, East Asia and Oceania ,2012-2016,Million
Table 150: Prevalence of Musculoskeletal Disorders in South East Asia, East Asia and Oceania ,(2012-2016, Million)
Table 151: Total Number of People With Cardiovascular Disorders in South East Asia, East Asia and Oceania , By Type,2016
7.7.6 By Distribution Channel, By Value (2013-2023)
Table 152: Asia Pacific Sterile Injectables Market : By Distribution Channel, By Value, 2013-2023 (USD Billion)
7.8 APAC Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
Table 153: Asia Pacific Sterile Injectables Market, Country Share, 2017 (% of Total)
Table 154: Asia Pacific Sterile Injectables, Country Share, 2023 (% of Total)
7.8.1 China Sterile Injectables Market, By Value (2013-2023)
Table 155: China Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 156: China Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Table 157: China Healthcare Expenditure (2012-2016, USD Billion)
Table 158: China Population 65 Years & Above (% of Total),2012-2016 )
7.8.2 China Sterile Injectables Market, By Indication, By Value (2013-2023)
Table 159: China Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 160: China Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016
Table 161: China Prevalence of Disorders (Per 1,00,000 )2013-2016
Table 162: China Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
7.8.3 Japan Sterile Injectables Market, By Value (2013-2023)
Table 163: Japan Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 164: Japan Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Table 165: Japan Per Capita Health Expenditure (2012-2016,USD)
Table 166: Japan Population 65 Years & Above (% of Total), 2012-2016
7.8.4 Japan Injectables Market, By Indication, By Value (2013-2023)
Table 167: Japan Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 168: Japan Prevalence of Diabetes Mellitus (Per 1,00,000 )2013-2016
Table 169: Japan Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Table 170: Japan Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
7.8.5 India Sterile Injectables Market, By Value (2013-2023)
Table 171: India Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 172: India Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
7.8.6 India Injectables Market, By Indication, By Value (2013-2023)
Table 173: India Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 174: India Prevalence of Diabetes Mellitus Per 1,00,000 )2013-2016
Table 175: India Prevalence of Musculoskeletal Disorders (Per 1,00,000 )2013-2016
Table 176: India Prevalence of Cardiovascular Disorders (Per 1,00,000) 2013-2016
Table 177: Total Number of People With Infectious Disorder in India (2012-2016)
7.8.7 Rest of APAC Sterile Injectables Market, By Value (2013-2023)
Table 178: Rest of Asia Pacific Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 179: Rest of Asia Pacific Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
7.9 Rest of the World Sterile Injectables Market: An Analysis
7.9.1 By Value (2013-2017)
Table 180: Rest of World Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
7.9.2 By Value (2018-2023)
Table 181: Rest of World Sterile Injectables Market Size, By Value, Forecast, 2018-2023(USD Billion )
7.9.3 By Molecule Type, By Value (2013-2023)
Table 182: Rest of World Sterile Injectables Market: By Molecule Type, By Value, 2013-2023 (USD Billion)
Table 183: Rest of World Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 184: Prevalence of Infectious Disorder in Middle East and North Africa Region (2012-2016, Million)
Table 185: Prevalence of Infectious Disorder in Middle East and North Africa Region (2012-2016, Million)
Table 186: Prevalence of Sense Organ Disorders in Middle East and North Africa Region (2012-2016, Million)
7.9.4 By Biologic Drug Type, By Value (2013-2023)
Table 187: Rest of World Sterile Injectables Market : By Biologic Drug Type, By Value, 2013-2023 (USD Billion)
7.9.5 By Distribution Channel, By Value (2013-2023)
Table 188: Rest of World Sterile Injectables Market : By Distribution Channel, By Value, 2013-2023 (USD Billion)
7.10 Rest of the World Sterile Injectables Market, Country Share Analysis: 2017(%) and 2023F (%)
Table 189: Rest of World Sterile Injectables Market, Country Share, 2017 (% of Total)
Table 190: Rest of World Sterile Injectables , Country Share, 2023 (% of Total)
7.5.1 Brazil Sterile Injectables Market, By Value (2013-2023)
Table 191: Brazil Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 192: Brazil Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
7.5.2 Brazil Sterile Injectables Market, By Indication, By Value (2013-2023)
Table 193: Brazil Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 194: Brazil Prevalence of Diabetes (Per 1,00,000 )2013-2016
Table 195: Brazil Prevalence of Disorders (Per 1,00,000 )2013-2016
Table 196: Brazil Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Table 197: Total Number of People With Infectious Disorder in Brazil (2012-2016)
7.5.3 Saudi Arabia Sterile Injectables Market, By Value (2013-2023)
Table 198: Saudi Arabia Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 199: Saudi Arabia Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
7.5.4 Saudi Arabia Injectables Market, By Indication, By Value (2013-2023)
Table 200: Saudi Arabia Sterile Injectables Market : By Indication, By Value, 2013-2023 (USD Billion)
Table 201: Saudi Arabia Prevalence of Cardiovascular Disorders (Per 1,00,000 )2013-2016
Table 202: Saudi Arabia Prevalence of Diabetes (Per 1,00,000 )2013-2016
Table 203: Saudi Arabia Prevalence of Disorders (Per 1,00,000 )2013-2016
Table 204: Total Number of People With Infectious Disorder in Saudi Arabia (2012-2016)
7.5.5 Other Sterile Injectables Market, By Value (2013-2023)
Table 205: Others Sterile Injectables Market Size, By Value, 2013-2017 (USD Billion)
Table 206: Others Sterile Injectables Market Size By Value, 2018E-2023F (USD Billion)
Table 207: Pfizer, Revenue, 2015-2017 (USD Millions)
Table 208: Pfizer Segmental Breakup, 2017 (%)
Table 209: Pfizer Sales, By Country, 2017 (%)
8. Global Sterile Injectables Market Dynamics
8.1 Global Sterile Injectables Market Drivers
8.2 Global Sterile Injectables Market Restraints
9. Global Sterile Injectables Market Trends
10. Policy and Regulatory Landscape
11. Porter Five Force Analysis
12. SWOT Analysis
13. Company Profile
13.1 Sanofi
13.2 Pfizer
13.3 Baxer International
Table 210: Baxter International, Revenues, 2014-2016 (USD Billion)
Table 211: Baxter International, Net Sales, By Segment, 2016 (%)
Table 212: Baxter International, Net Sales, By Region, 2016 (%)
13.4 Glaxosmithkline
13.5 Novartis
Table 213: Novartis, Sales, 2013-2017 (USD Millions)
Table 214: Novartis Sales, By Segment 2017 (%)
Table 215: Novartis Sales, By Geography,2017 (%)
13.6 Gilead Sciences
Table 216: Gilead Sciences Product Sales, 2016 (%)
Table 217: Gilead Sciences HCV Product Sales, 2014-2016 (USD Billion)
13.7 Merck & Co.
Table 218: Net Sales, By Geographic Location, % Share 2016
Table 219: Net Revenue, By Business Segment, % Share 2017
Table 220: Net Sales, 2014-2017 (In million USD)
13.8 Astra Zeneca